Literature DB >> 23567394

Patterns of reduced cortical thickness in late-life depression and relationship to psychotherapeutic response.

R Scott Mackin1, Duygu Tosun, Susanne G Mueller, Jun-Young Lee, Philip Insel, Norbert Schuff, Diana Truran-Sacrey, Patricia Arean, J Craig Nelson, Michael W Weiner.   

Abstract

OBJECTIVE: Cortical atrophy has been associated with late-life depression (LLD) and recent findings suggest that reduced right hemisphere cortical thickness is associated with familial risk for major depressive disorder, but cortical thickness abnormalities in LLD have not been explored. Furthermore, cortical atrophy has been posited as a contributor to poor antidepressant treatment response in LLD, but the impact of cortical thickness on psychotherapy response is unknown. This study was conducted to evaluate patterns of cortical thickness in LLD and in relation to psychotherapy treatment outcomes.
METHODS: Participants included 22 individuals with LLD and 12 age-matched comparison subjects. LLD participants completed 12 weeks of psychotherapy and treatment response was defined as a 50% reduction in depressive symptoms. All participants underwent magnetic resonance imaging of the brain, and cortical mapping of gray matter tissue thickness was calculated.
RESULTS: LLD individuals demonstrated thinner cortex than controls prominently in the right frontal, parietal, and temporal brain regions. Eleven participants (50%) exhibited positive psychotherapy response after 12 weeks of treatment. Psychotherapy nonresponders demonstrated thinner cortex in bilateral posterior cingulate and parahippocampal cortices, left paracentral, precuneus, cuneus, and insular cortices, and the right medial orbitofrontal and lateral occipital cortices relative to treatment responders.
CONCLUSIONS: Our findings suggest more distributed right hemisphere cortical abnormalities in LLD than have been previously reported. In addition, our findings suggest that reduced bilateral cortical thickness may be an important phenotypic marker of individuals at higher risk for poor response to psychotherapy.
Copyright © 2013 American Association for Geriatric Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Atrophy; MRI; cortical thickness; geriatric; late-life depression; psychotherapy

Mesh:

Year:  2013        PMID: 23567394      PMCID: PMC3732520          DOI: 10.1016/j.jagp.2013.01.013

Source DB:  PubMed          Journal:  Am J Geriatr Psychiatry        ISSN: 1064-7481            Impact factor:   4.105


  39 in total

1.  More disappointing treatment outcomes in late-life depression.

Authors:  S I Evans
Journal:  Br J Psychiatry       Date:  2000-09       Impact factor: 9.319

2.  MRI signal hyperintensities and treatment remission of geriatric depression.

Authors:  Faith M Gunning-Dixon; Michael Walton; Janice Cheng; Jessica Acuna; Sibel Klimstra; Molly E Zimmerman; Adam M Brickman; Matthew J Hoptman; Robert C Young; George S Alexopoulos
Journal:  J Affect Disord       Date:  2010-05-07       Impact factor: 4.839

3.  Differential cortical atrophy in subgroups of mild cognitive impairment.

Authors:  Sandra Bell-McGinty; Oscar L Lopez; Carolyn Cidis Meltzer; Joelle M Scanlon; Ellen M Whyte; Steven T Dekosky; James T Becker
Journal:  Arch Neurol       Date:  2005-09

4.  CRUISE: cortical reconstruction using implicit surface evolution.

Authors:  Xiao Han; Dzung L Pham; Duygu Tosun; Maryam E Rettmann; Chenyang Xu; Jerry L Prince
Journal:  Neuroimage       Date:  2004-11       Impact factor: 6.556

5.  Early-life risk factors for late-onset depression.

Authors:  Joel R Sneed; Stephanie Kasen; Patricia Cohen
Journal:  Int J Geriatr Psychiatry       Date:  2007-07       Impact factor: 3.485

6.  Reduction of orbital frontal cortex volume in geriatric depression.

Authors:  T Lai; M E Payne; C E Byrum; D C Steffens; K R Krishnan
Journal:  Biol Psychiatry       Date:  2000-11-15       Impact factor: 13.382

7.  The functional neuroanatomy of geriatric depression.

Authors:  Gwenn S Smith; Elisse Kramer; Yilong Ma; Peter Kingsley; Vijay Dhawan; Thomas Chaly; David Eidelberg
Journal:  Int J Geriatr Psychiatry       Date:  2009-08       Impact factor: 3.485

8.  Orbitofrontal cortex function and structure in depression.

Authors:  Wayne C Drevets
Journal:  Ann N Y Acad Sci       Date:  2007-09-13       Impact factor: 5.691

Review 9.  Efficacy of second generation antidepressants in late-life depression: a meta-analysis of the evidence.

Authors:  J Craig Nelson; Kevin Delucchi; Lon S Schneider
Journal:  Am J Geriatr Psychiatry       Date:  2008-07       Impact factor: 4.105

10.  Independent cognitive effects of atrophy and diffuse subcortical and thalamico-cortical cerebrovascular disease in dementia.

Authors:  Richard H Swartz; Donald T Stuss; Fuqiang Gao; Sandra E Black
Journal:  Stroke       Date:  2008-02-07       Impact factor: 7.914

View more
  20 in total

1.  Brain structural connectivity in late-life major depressive disorder.

Authors:  Stephen F Smagula; Howard J Aizenstein
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2016-05

2.  Increases in orbitofrontal cortex thickness following antidepressant treatment are associated with changes in resting state autonomic function in adolescents with major depression - Preliminary findings from a pilot study.

Authors:  Julian Koenig; Melinda Westlund Schreiner; Bonnie Klimes-Dougan; Benjamin Ubani; Bryon A Mueller; Kelvin O Lim; Michael Kaess; Kathryn R Cullen
Journal:  Psychiatry Res Neuroimaging       Date:  2018-08-24       Impact factor: 2.376

3.  Development and evaluation of a multimodal marker of major depressive disorder.

Authors:  Jie Yang; Mengru Zhang; Hongshik Ahn; Qing Zhang; Tony B Jin; Ien Li; Matthew Nemesure; Nandita Joshi; Haoran Jiang; Jeffrey M Miller; Robert Todd Ogden; Eva Petkova; Matthew S Milak; Mary Elizabeth Sublette; Gregory M Sullivan; Madhukar H Trivedi; Myrna Weissman; Patrick J McGrath; Maurizio Fava; Benji T Kurian; Diego A Pizzagalli; Crystal M Cooper; Melvin McInnis; Maria A Oquendo; Joseph John Mann; Ramin V Parsey; Christine DeLorenzo
Journal:  Hum Brain Mapp       Date:  2018-08-16       Impact factor: 5.038

Review 4.  Epigenetic and Neural Circuitry Landscape of Psychotherapeutic Interventions.

Authors:  Christopher W T Miller
Journal:  Psychiatry J       Date:  2017-05-25

5.  Cortical Thickness and Depressive Symptoms in Cognitively Normal Individuals: The Mayo Clinic Study of Aging.

Authors:  Anna Pink; Scott A Przybelski; Janina Krell-Roesch; Gorazd B Stokin; Rosebud O Roberts; Michelle M Mielke; David S Knopman; Clifford R Jack; Ronald C Petersen; Yonas E Geda
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

6.  Imaging correlates of depression in progressive supranuclear palsy.

Authors:  Daniele Urso; Benedetta Tafuri; Roberto De Blasi; Salvatore Nigro; Giancarlo Logroscino
Journal:  J Neurol       Date:  2022-01-08       Impact factor: 4.849

Review 7.  Neuroimaging for psychotherapy research: current trends.

Authors:  Carol P Weingarten; Timothy J Strauman
Journal:  Psychother Res       Date:  2014-02-17

8.  Increased involvement of the parahippocampal gyri in a sad mood predicts future depressive symptoms.

Authors:  Vera Zamoscik; Silke Huffziger; Ulrich Ebner-Priemer; Christine Kuehner; Peter Kirsch
Journal:  Soc Cogn Affect Neurosci       Date:  2014-02-03       Impact factor: 3.436

9.  Chronic Depressive Symptomatology in Mild Cognitive Impairment Is Associated with Frontal Atrophy Rate which Hastens Conversion to Alzheimer Dementia.

Authors:  Simona Sacuiu; Philip S Insel; Susanne Mueller; Duygu Tosun; Niklas Mattsson; Clifford R Jack; Charles DeCarli; Ronald Petersen; Paul S Aisen; Michael W Weiner; R Scott Mackin
Journal:  Am J Geriatr Psychiatry       Date:  2015-03-30       Impact factor: 4.105

10.  Cortical Thickness and Hippocampal Volume in Vascular and Non-vascular Depressed Patients.

Authors:  Dakota A Egglefield; Sophie Schiff; Jeffrey N Motter; Alice Grinberg; Bret R Rutherford; Joel R Sneed
Journal:  Front Psychiatry       Date:  2021-07-14       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.